WHO Seeks Clarity on Child ‘Pneumonia Clusters’ in China: Urges Protective Measures

WHO Seeks Clarity on Child 'Pneumonia Clusters' in China Urges Protective Measures

Amid reports of “clusters of undiagnosed pneumonia” affecting children in northern China, the World Health Organization (WHO) has formally requested more information from Chinese authorities. Non-state media has highlighted overwhelmed pediatric hospitals in certain regions, prompting concerns.

AstraZeneca Faces Legal Challenge Over Alleged Covid Vaccine Injury

AstraZeneca Faces Legal Challenge Over Alleged Covid Vaccine Injury

AstraZeneca faces litigation from a man claiming severe brain damage after receiving their COVID vaccine. The man, Jamie Scott, asserts the vaccine wasfaulty under the Consumer Protection Act. 80 more lawsuits are expected, and the case could challenge outdated compensation practices. Initially recommended for all adults, AstraZeneca’s vaccine use was later restricted due to rare blood clot incidents. Despite these cases, AstraZeneca upholds the vaccine’s safety based on clinical trials and global standards.

Impact of COVID-19 on Brain Health in Over-50s: Study Reveals Concerning Decline

Impact of COVID-19 on Brain Health in Over-50s Study Reveals Concerning Decline

A recent study conducted in the UK with over 3,000 participants aged 50 and above reveals an apparent decline in brain health among this demographic during the COVID-19 pandemic. The research suggests a negative impact on cognitive function, regardless of actual COVID-19 infection, highlighting potential explanations and concerns regarding stress, loneliness, and alcohol consumption.

FDA Approves Updated COVID-19 Booster Shots: What You Need to Know

FDA Approves New COVID Booster Shots

The U.S. Food and Drug Administration (FDA) has given the green light to updated COVID-19 booster shots from Pfizer and Moderna, marking a significant development in the ongoing battle against the virus. These booster shots are designed to combat the XBB.1.5 Omicron subvariant, are fully approved for individuals aged 12 and older, and are authorized for emergency use in those aged 6 months through 11 years.